KURA insider trades & Congress trades
Kura Oncology, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 14 open-market insider transactions in Kura Oncology, Inc. (KURA) (2 purchases with code P and 12 sales with code S), the most recent on September 29, 2026.
In the last 90 days: 2 purchases by 1 insider ($2.35M) and 12 sales by 6 ($1.71M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Ford Kathleen | Chief Operating Officer | Sell | 3,668 | $10.75 | $39K | −0.0% |
| Sep 29, 2026 | Leoni Mollie | Chief Medical Officer | Sell | 28,802 | $10.75 | $310K | −0.0% |
| Sep 29, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 15,430 | $10.75 | $166K | −0.0% |
| Sep 28, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,442 | $10.50 | $89K | −0.0% |
| Sep 28, 2026 | Ford Kathleen | Chief Operating Officer | Sell | 6,906 | $10.50 | $72K | −0.0% |
| Sep 28, 2026 | Leoni Mollie | Chief Medical Officer | Sell | 12,448 | $10.50 | $131K | −0.0% |
| Sep 28, 2026 | Doyle Thomas James | SVP, Finance & Accounting | Sell | 4,607 | $10.50 | $48K | −0.0% |
| Sep 28, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 9,020 | $10.50 | $95K | −0.0% |
| Sep 28, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 8,000 | $10.56 | $84K | −0.0% |
| Sep 24, 2026 | Burrows Francis | Chief Scientific Officer | Sell | 20,726 | $10.83 | $225K | −0.1% |
| Aug 24, 2026 | Wilson Troy Edward | President and CEO | Buy | 100,000 | $12.39 | $1.24M | −0.1% |
| Aug 21, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 4,345 | $11.89 | $52K | −0.1% |
| Aug 19, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | 31,487 | $12.63 | $398K | −0.0% |
| Aug 17, 2026 | Wilson Troy Edward | President and CEO | Buy | 100,000 | $11.12 | $1.11M | −0.0% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.